Refractory Acute Myeloid Leukemia (AML)
5 clinical trials · Condition
◉ Watch Refractory Acute Myeloid Leukemia (AML)
| Record | Firm | Date |
|---|---|---|
| A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT03787498) | Opna Bio LLC | 2019-03-19 |
Track Refractory Acute Myeloid Leukemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.